Banzai investor increases stake to 18.7% through warrant exercise

Banzai International Inc. (NASDAQ: BNZI) announced that an institutional investor exercised pre-funded warrants to increase its ownership stake to approximately 18.7% of the company's outstanding Class A common stock.

The investor exercised 1,176,628 pre-funded warrants on October 9 through a cashless transaction. The warrants had an exercise price of $0.001 per share and were originally issued as part of Banzai's acquisition of ClearDoc Inc. in December 2024.

As consideration for the ClearDoc acquisition, Banzai issued securities in a private placement to certain ClearDoc shareholders on December 18, 2024. The institutional investor received 49,996 shares of Class A common stock and 1,176,950 pre-funded warrants as part of that transaction.

The company stated that the investor has not sold any shares issued under the private placement. Following the warrant exercise, all pre-funded warrants issued in connection with the ClearDoc acquisition have been exercised.

"This warrant exercise by a key institutional shareholder demonstrates the continued confidence in our long-term strategy," said Joe Davy, founder and CEO of Banzai. "We continue to appreciate the long-term support from all stakeholders."

Banzai describes itself as a marketing technology company that provides AI-enabled marketing and sales solutions for businesses. The company reports having over 140,000 customers including RBC, Dell Technologies, New York Life, Thermo Fisher Scientific, Thinkific, and ActiveCampaign.

You May Also Be Interested In

• Kimbell Royalty closes $221.2M mineral rights acquisition
• Oruka Therapeutics (ORKA) files $1B mixed shelf
• Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders